Aortic Stenosis - Prognosis, Risk and Outcomes

Recruiting Observational Study
Aortic Stenosis Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
300 (estimated)
Sponsor
Vastra Gotaland Region · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The investigators will prospectively enroll 300 patients undergoing TAVI at Sahlgrenska University Hospital, which is the second largest TAVI hospital in Sweden. Eligible patients should have a clinical indication for aortic valve replacement with TAVI and have preprocedural clinical investigations with echocardiography (UCG) and CCT and provide written informed consent. UCG, electrocardiogram (EC…
Trial Locations

Sorted by distance from Montana

Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient with clinical indication for aortic valve replacement and scheduled for TAVI * Patient willing and able to provide signed informed consent Exclusion Criteria: * Inability to provide informed consent Additional exclusion criteria for MRI * Estimated glomerular filtrat…
Contacts

Oskar Angerås, MD, PhD

+46 313421000

oskar.angeras@vgregion.se

CONTACT

Björn Redfors, MD, PhD, Professor

031342100

bjoern.redfors@wlab.gu.se

CONTACT